| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/02/2014 | CN103893397A 一种瑞香狼毒提取物胃内漂浮片 One kind Stellera chamaejasme extract complex floating piece |
| 07/02/2014 | CN103893244A 透骨草在抑制畜禽大肠杆菌对抗菌药的耐药性上的应用 Speranskia application of antibacterial drugs inhibit livestock coli resistance on |
| 07/02/2014 | CN103893133A 一种冻干赋型制剂的配方及其制备方法 Shaping a lyophilized preparation of the recipe and preparation method |
| 07/02/2014 | CN103893126A 一种包埋抗寄生虫药物的壳聚糖纳米粒及其制备方法 An antiparasitic preparation of chitosan nanoparticles and embedding |
| 07/02/2014 | CN102813926B miR-7表达抑制剂在制备治疗系统性红斑狼疮药物中的应用 miR-7 expression inhibitor for the manufacture of a medicament for the treatment of systemic lupus erythematosus |
| 07/02/2014 | CN102665678B 用于copd的联合治疗 For the combination therapy copd |
| 07/02/2014 | CN102533972B 作为心血管病的标志和治疗靶的1l1rl-1 As a sign of cardiovascular disease and therapeutic targets of 1l1rl-1 |
| 07/02/2014 | CN102526771B 包封uspio的隐形纳米脂质体注射液及其制备方法与应用 Stealth nano-encapsulated liposome injection and its preparation method and application uspio of |
| 07/02/2014 | CN102526002B 自行破坏的透皮治疗系统 Transdermal therapeutic system of self-destruct |
| 07/02/2014 | CN102218027B 一种包载难溶性抗肿瘤药物的聚合物胶束冻干制剂 One kind of poorly soluble anticancer drugs entrapped polymer micelle lyophilized preparation |
| 07/02/2014 | CN102170911B 用于治疗再灌注损伤的方法 The method used for the treatment of reperfusion injury |
| 07/02/2014 | CN102137682B 抗丙型肝炎病毒组合物 Anti-hepatitis C virus composition |
| 07/01/2014 | US8765960 6-((S)-1- {1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1H-pyrazol-3-YL}-ethyl)-3H-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent AMPA receptor antagonist |
| 07/01/2014 | US8765930 RNA interference mediating small RNA molecules |
| 07/01/2014 | US8765790 Positive allosteric modulators of nicotinic acetylcholine receptor |
| 07/01/2014 | US8765729 Cancer therapy |
| 07/01/2014 | US8765711 Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage |
| 07/01/2014 | US8765680 Method for administering omega-conopeptide |
| 07/01/2014 | US8765674 Methods useful in the treatment of bone resorption diseases |
| 07/01/2014 | US8765146 Adenoviral vector-based malaria vaccines |
| 07/01/2014 | US8765139 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 07/01/2014 | US8765120 Muscle-derived cells (MDCS) for augmenting or bulking urethral sphincter-muscle tissue |
| 07/01/2014 | US8765119 Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells |
| 07/01/2014 | US8763604 Methods for treating allergy |
| 06/26/2014 | WO2014100735A2 Diazole amides |
| 06/26/2014 | WO2014100292A1 Treatment of circadian rhythm disorders |
| 06/26/2014 | WO2014100014A1 Super-2 complexes with antibody to augment il-2 therapy |
| 06/26/2014 | WO2014098249A1 Composition having tissue repairing activity and utilization thereof |
| 06/26/2014 | WO2014098232A1 Pharmaceutical composition comprising pi3 kinase inhibitor, pharmaceutical composition comprising compound which acts on vitamin d receptor, freeze-dried composition, method for producing freeze-dried composition, and pharmaceutical composition for transpulmonary administration |
| 06/26/2014 | WO2014098210A1 Apoptosis-inducing agent |
| 06/26/2014 | WO2014097875A1 Development of pluripotent stem cell employing novel dedifferentiation induction method |
| 06/26/2014 | WO2014097648A1 Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective |
| 06/26/2014 | WO2014095088A1 Egfr targeted therapy of neurological disorders and pain |
| 06/26/2014 | WO2014094138A1 Screening methods to identify compounds inhibiting the activity of e2 enzymes by stabilization of non-covalent ubiquitin-e2 complexes and pharmaceutical applications related to e2 inhibitors |
| 06/26/2014 | US20140179903 High Affinity Human Antibodies to Human Protease-Activated Receptor 2 |
| 06/26/2014 | US20140179799 Small molecule modulators of microrna-34a |
| 06/26/2014 | US20140179733 Diazole amides |
| 06/26/2014 | US20140179710 Antiviral salts |
| 06/26/2014 | US20140179693 Methods for treating vascular leak syndrome |
| 06/26/2014 | US20140179690 Fused aminodihydrothiazine derivatives |
| 06/26/2014 | US20140179689 Novel rho kinase inhibitors and methods of use |
| 06/26/2014 | US20140179679 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
| 06/26/2014 | US20140179672 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use |
| 06/26/2014 | US20140179665 Hepatitis b antiviral agents |
| 06/26/2014 | US20140179662 Pharmaceutically active disubstituted triazine derivatives |
| 06/26/2014 | US20140179658 Methods and compositions for stimulation and enhancement of regeneration of tissues |
| 06/26/2014 | US20140179648 Novel Heterocyclic Compounds as Bromodomain Inhibitors |
| 06/26/2014 | US20140179647 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors |
| 06/26/2014 | US20140179639 Meloxicam for the treatment of respiratory diseases in pigs |
| 06/26/2014 | US20140179625 Sodium channel blockers |
| 06/26/2014 | US20140179623 Ectoparasiticidal active substance combinations |
| 06/26/2014 | US20140179622 Novel compound isolated from quamoclit, and composition for preventing or treating diabetes containing the compound as an active ingredient |
| 06/26/2014 | US20140179613 COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF |
| 06/26/2014 | US20140179608 Materials and Methods Related to Sodium/Potassium Adenosine Triphosphatase and SRC |
| 06/26/2014 | US20140179607 Treatments for Gastrointestinal Disorders |
| 06/26/2014 | US20140179606 Left ventricular diastolic function improving agent |
| 06/26/2014 | US20140179601 Fgf-9 and its use relating to blood vessels |
| 06/26/2014 | US20140179595 Apolipoprotein e polypeptides and their use |
| 06/26/2014 | US20140178503 Cyclohexyl urea modulators of d2 receptors and/or d3 receptors |
| 06/26/2014 | US20140178488 Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans |
| 06/26/2014 | US20140178487 Camel hump oil - based herbal compositions and method of making the same |
| 06/26/2014 | US20140178472 Methods of Regulating Glucose Metabolism, and Reagents Related Thereto |
| 06/26/2014 | US20140178465 Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury |
| 06/26/2014 | US20140178463 Compositions for treating cmt and related disorders |
| 06/26/2014 | US20140178461 Compounds and compositions for use in the treatment and prevention of lung and brain cancer and precancerous conditions thereof |
| 06/26/2014 | US20140178453 Devices and methods for the regeneration of bony defects |
| 06/26/2014 | US20140178449 Methods for treating parkinson's disease |
| 06/26/2014 | US20140178441 Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| 06/26/2014 | US20140178417 Methods for treating cancer using an immunotoxin |
| 06/26/2014 | US20140178403 Method of inhibiting binding or activity of mif by administering a mif antagonist |
| 06/26/2014 | US20140178402 Pharmaceutical compositions comprising human antibodies to pcsk9 |
| 06/26/2014 | US20140178397 Anti-angiogenic therapy |
| 06/26/2014 | US20140178392 Nogo Receptor-Mediated Blockade of Axonal Growth |
| 06/26/2014 | US20140178380 Bi-Specific Fusion Proteins |
| 06/26/2014 | US20140178374 Bax agonist, compositions, and methods related thereto |
| 06/26/2014 | US20140178373 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 06/26/2014 | US20140178369 Treatment with anti-vegf antibodies |
| 06/26/2014 | US20140178360 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS |
| 06/26/2014 | US20140178354 Salinosporamides and Methods of Use Thereof |
| 06/26/2014 | US20140178349 Cycloalkyl-Substituted Imidazole Derivative |
| 06/26/2014 | US20140178338 4'-fluoro nuclosides for the treatment of hcv |
| 06/26/2014 | US20140178337 Hepatitis b antiviral agents |
| 06/26/2014 | US20140178332 IL-12/p40 BINDING PROTEINS |
| 06/26/2014 | US20140178331 Method of treating cerebral hemorrhage and subarachnoid hemorrhage comprising administering metal chelators to the upper one-third of the nasal cavity |
| 06/26/2014 | US20140178295 Method for Treating Psoriasis By Administering An Anti-IL-12 Antibody |
| 06/26/2014 | US20140178294 Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration |
| 06/26/2014 | DE102012024749A1 Tumorprävention und -therapie durch Induktion einer Tumorseneszenz Tumor prevention and therapy by inducing Tumorseneszenz |
| 06/25/2014 | EP2745847A1 Progestins for preventing or reducing neurodeneration or ischemic damage |
| 06/25/2014 | EP2745846A1 Drug for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor gc-a agonist and gc-b agonist |
| 06/25/2014 | EP2744494A1 Combination cancer therapy of hsp90 inhibitor with antimetabolite |
| 06/25/2014 | EP2744493A1 Combinations of a 5-ht4 receptor agonist and a pde4 inhibitor for use in therapy |
| 06/25/2014 | CN103889453A 肿瘤选择性趋化因子调节 Tumor-selective chemokine regulation |
| 06/25/2014 | CN103889422A 治疗胃肠道间质瘤的方法 Gastrointestinal stromal tumors method of treatment |
| 06/25/2014 | CN103889418A 使用PI3Kβ抑制剂和包括MEK和RAF抑制剂的MAPK通道抑制剂治疗癌症的组合物和方法 Use PI3Kβ including MAPK inhibitors and inhibitors of RAF and MEK channel inhibitors for cancer treatment compositions and methods |
| 06/25/2014 | CN103882124A 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物 Methods and compositions for the diagnosis, prognosis and treatment of breast cancer is based MicroRNA |
| 06/25/2014 | CN103877585A 壳聚糖衍生物纳米粒子和载药纳米粒子及制备方法 Chitosan derivative nanoparticles and nanoparticle drug and preparation methods |
| 06/25/2014 | CN103877576A Caspase激活及募集结合域3（Card3）基因在冠状动脉粥样硬化性心脏病中的功能和应用 Caspase activation and recruitment binding function and application domains 3 (Card3) gene in coronary atherosclerotic heart disease |
| 06/25/2014 | CN103877065A 一种脂质载体与难溶性药物组合物及其制备方法 A lipid carrier and insoluble drug composition and preparation method |
| 06/25/2014 | CN103143024B 一种植入型补肾健骨中药提取物-抗生素-硫酸钙缓释系统及其制备方法和应用 An implantable Bushenjiangu extract of Chinese medicine - antibiotics - calcium sulfate sustained-release system and its preparation method and application |
| 06/25/2014 | CN102395365B 用于治疗或预防皮肤疾病的阿维菌素或米尔倍霉素与肾上腺素能受体的组合 The treatment or prevention of skin disorders, or a combination of avermectin and milbemycin adrenergic receptors for |